Acumen Pharmaceuticals (ABOS) Research & Development (2020 - 2026)
Acumen Pharmaceuticals (ABOS) recorded Research & Development of $27.81 million in Q2 2026, down 25.1% from $37.13 million a year earlier but up 68.7% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Acumen Pharmaceuticals' Research & Development came in at $86.79 million as of Jun 30, 2026, down 30.1% year-over-year; for FY2025, it was $104.89 million, up 11.8% from FY2024.
- Annual Research & Development has increased for five straight years, with a five-year compound annual growth rate of 67.3% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $93.8 million in FY2024 (+121.7%), $42.32 million in FY2023 (+30.8%), $32.36 million in FY2022 (+163.0%) and $12.31 million in FY2021 (+53.9%).
- Quarterly Research & Development has ranged from $1.8 million in Q3 2021 to $37.13 million in Q2 2025 over the past five years.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with growth averaging 47.1% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 452.9% in Q4 2021, against a decline of 40.6% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.48 million (Q1 2026), $20.53 million (Q4 2025) and $21.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Acumen Pharmaceuticals | 147.03 Mn | -335.04 Mn | - | 27.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.81 Mn |
| Mar 31, 2026 | 16.48 Mn |
| Dec 31, 2025 | 20.53 Mn |
| Sep 30, 2025 | 21.97 Mn |
| Jun 30, 2025 | 37.13 Mn |
| Mar 31, 2025 | 25.27 Mn |
| Dec 31, 2024 | 34.57 Mn |
| Sep 30, 2024 | 27.25 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 12.45 Mn |
| Dec 31, 2023 | 13.29 Mn |
| Sep 30, 2023 | 11.18 Mn |
| Jun 30, 2023 | 9.13 Mn |
| Mar 31, 2023 | 8.71 Mn |
| Dec 31, 2022 | 10.75 Mn |
| Sep 30, 2022 | 8.31 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Mar 31, 2022 | 5.99 Mn |
| Dec 31, 2021 | 5.67 Mn |
| Sep 30, 2021 | 1.80 Mn |
API Access
Acumen Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();